At the conclusion of this educational activity, the participant should be able to:
1) Explain pathophysiology of TTP and how caplacizumab helps the patient 
2) Describe registry protocol, patient demographics, adverse events
3) Summarize treatment courses and how long it took for platelet count/ADAMTS-13 normalization
4) All patients responded to the medication

Session date: 
01/29/2025 - 3:00pm to 4:00pm EST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Completion
  • 1.00 Nursing CEU
Please login or register to take this course.